Somalia vs Timor-Leste: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Somalia
4.0%
in 2024
Timor-Leste
1.0%
in 2024
Somalia rank
2nd
Timor-Leste rank
3rd
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Somalia
- Timor-Leste
How they compare
Somalia currently reports 4.0% against 1.0% in Timor-Leste, a difference of 3.0%.
That makes Somalia's figure about 4.0 times Timor-Leste's.
Across all 10 years both countries report, Somalia has been ahead every year.
Somalia ranks 2nd and Timor-Leste ranks 3rd of 215 countries.
Somalia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Somalia | Timor-Leste | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6.4% | 2.5% | 4.0% | Somalia |
| 2020s | 4.4% | 1.3% | 3.1% | Somalia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Somalia or Timor-Leste?
- Somalia, at 4.0% against 1.0% in Timor-Leste as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Somalia and Timor-Leste?
- 3.0%, with Somalia ahead.
- How many years of comparable data are there for Somalia and Timor-Leste?
- 10 years are reported by both, from 2015 to 2024.
- How do Somalia and Timor-Leste rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Somalia ranks 2nd and Timor-Leste ranks 3rd of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.